Published in Adv Enzyme Regul on January 01, 1992
Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci U S A (1994) 0.97
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression. Br J Cancer (1996) 0.95
Genomic imbalances associated with acquired resistance to platinum analogues. Am J Pathol (1999) 0.85
An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield. J Virol (1993) 0.84
Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res (1996) 0.83
Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Br J Cancer (1994) 0.82
Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance. Cytotechnology (1998) 0.75
The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J (1996) 4.55
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun (2001) 2.24
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science (1991) 2.18
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells (2001) 1.95
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology (2000) 1.76
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.62
Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol (1998) 1.57
Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci U S A (1985) 1.57
Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol (1999) 1.56
Fine needle aspiration in the diagnosis of metastatic melanoma. J Am Acad Dermatol (2000) 1.56
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Eur J Cancer (1994) 1.49
Cricothyrotomy technique: standard versus the Rapid Four-Step Technique. J Emerg Med (1999) 1.47
Detection of drug resistance in human tumors by in vitro enzymatic amplification. Cancer Res (1988) 1.40
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci U S A (1991) 1.37
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res (1996) 1.35
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol (1999) 1.30
Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama (1983) 1.27
Inversely repeating integrated hepatitis B virus DNA and cellular flanking sequences in the human hepatoma-derived cell line huSP. Proc Natl Acad Sci U S A (1985) 1.25
Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J Biol Chem (1980) 1.25
Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. J Biol Chem (2000) 1.25
Molecular and phylogenetic analyses of the haemagglutinin (H) proteins of field isolates of canine distemper virus from naturally infected dogs. J Gen Virol (1997) 1.17
Chylous ascites: a late complication of intra-abdominal Mycobacterium avium complex immune reconstitution syndrome in HIV-infected patients. Int J STD AIDS (2009) 1.17
Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human. Cancer Gene Ther (2008) 1.13
Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun (2001) 1.12
Nucleotide sequence and evolution of the rat mitochondrial cytochrome b gene containing the ochre termination codon. Gene (1982) 1.12
Rearrangement of the surface antigen gene of hepatitis B virus integrated in the human hepatoma cell lines. Nucleic Acids Res (1983) 1.07
Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res Dev (1992) 1.02
Enhancement of cell adhesion and spreading by a cartilage-specific noncollagenous protein, cartilage matrix protein (CMP/Matrilin-1), via integrin alpha1beta1. J Biol Chem (1999) 1.02
Isolation and characterization of collagenases I and II from Clostridium histolyticum. Biochim Biophys Acta (1965) 1.02
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. Proc Natl Acad Sci U S A (1988) 1.02
Tumor-associated mutations of rat mitochondrial transfer RNA genes. Nucleic Acids Res (1983) 1.01
A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem Biophys Res Commun (1994) 0.99
Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci U S A (1994) 0.97
Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II). Cancer Res (1986) 0.97
Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res (1983) 0.97
Serological analysis of canine distemper virus using an immunocapture ELISA. J Vet Med Sci (1996) 0.96
Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol (2000) 0.95
Use of the Trousseau dilator in cricothyrotomy. J Emerg Med (1999) 0.95
Purification of mammalian tumor (L1210) thymidylate synthetase by affinity chromatography on stable biospecific adsorbent. Stabilization of the enzyme with neutral detergents. J Biol Chem (1979) 0.94
Molecular basis of cisplatin resistance in human carcinomas: model systems and patients. Anticancer Res (1990) 0.94
Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine. Cancer Commun (1989) 0.93
Epidermoid cyst derived from an accessory spleen in the pancreas. A case report with literature survey. Acta Pathol Jpn (1991) 0.92
Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol (1998) 0.92
Amino acid membrane transport properties of L1210 cells resistant to cisplatin. Chemioterapia (1986) 0.92
Direct evidence for the expression of integrated hepatitis B virus DNA in human hepatoma tissue. Gan (1984) 0.92
Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells. J Biol Chem (1990) 0.92
Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest (1989) 0.92
The induction of cataracts by HIV-1 in transgenic mice. AIDS (1992) 0.92
Individual dose reconstruction among residents living in the vicinity of the Semipalatinsk nuclear test site using EPR spectroscopy of tooth enamel. Health Phys (2002) 0.92
Induction of interferon-alpha by interferon-beta, but not of interferon-beta by interferon-alpha, in the mouse. Virology (1990) 0.92
A case of Creutzfeldt-Jakob disease presenting with auditory agnosia as an initial manifestation. Eur Neurol (2000) 0.91
Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res (1995) 0.90
Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid. J Biol Chem (1988) 0.90
Protective effect of gypenosides against oxidative stress in phagocytes, vascular endothelial cells and liver microsomes. Cancer Biother (1993) 0.89
Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry (2012) 0.89
Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Gene Ther (2000) 0.89
The nucleotide and predicted amino acid sequence of the fusion protein of recent isolates of canine distemper virus in Japan. J Vet Med Sci (1998) 0.88
Nucleotide excision repair "a legacy of creativity". Mutat Res (2001) 0.88
Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol (2001) 0.88
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res (1994) 0.88
Oligonucleotides as modulators of cancer gene expression. Pharmacol Ther (1997) 0.88
Human activin betaA gene. Identification of novel 5' exon, functional promoter, and enhancers. J Biol Chem (1996) 0.88
Efficient gene expression in skin wound sites following local plasmid injection. J Invest Dermatol (2001) 0.88
Low-threshold 115-GHz continuous-wave modulational-instability erbium-doped fiber laser. Opt Lett (1997) 0.87
Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost (1995) 0.87
Broad substrate specificity of snake venom fibrinolytic enzymes: possible role in haemorrhage. Toxicon (1992) 0.87
Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil. Eur J Cancer (1990) 0.87
PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors. Bone Marrow Transplant (2012) 0.87
Cisplatin resistance in human cancers. Pharmacol Ther (1991) 0.86
Reduction of post-ischemic lung reperfusion injury by fibrinolytic activity suppression. Transplantation (1999) 0.86
Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin. Biochem Pharmacol (1988) 0.86
Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells. Adv Exp Med Biol (1993) 0.86
Reversal of cisplatin resistance in vivo by an anti-fos ribozyme. In Vivo (1997) 0.86
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression. Biochem Biophys Res Commun (2001) 0.85
Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol (2001) 0.85
Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma. Ann Surg Oncol (2001) 0.85
Assessment by transesophageal echography of atherosclerosis of the descending thoracic aorta in patients with hypercholesterolemia. Am J Cardiol (1999) 0.85
Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients. J Am Acad Dermatol (1996) 0.84
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells. Gene Ther (2000) 0.84
Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther (2001) 0.84
Clearance and distribution of acid-stable trypsin inhibitor (ASTI). Enzyme (1989) 0.83
Therapeutic applications of ribozymes. Pharmacol Ther (1995) 0.83
Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophageal pulsed Doppler echocardiography. Am J Cardiol (1993) 0.83
Inhibition of methionine transport by methotrexate in mitogen-stimulated human lymphocytes. Cancer Treat Rep (1983) 0.83
Recombinant gamma interferon induces HLA-DR expression on squamous cell carcinoma, trichilemmoma, adenocarcinoma cell lines, and cultured human keratinocytes. Arch Dermatol Res (1987) 0.83
[Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles]. Rinsho Shinkeigaku (1999) 0.83
Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res (1996) 0.83
Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris. Biochem Biophys Res Commun (1996) 0.83
Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol (2012) 0.83
Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells. Mol Pharmacol (1981) 0.83